Olr840 inhibitors represent a specialized class of chemical compounds that primarily function by binding to and modulating the activity of the olfactory receptor 840 (Olr840), a member of the G-protein-coupled receptor (GPCR) family. These receptors, found predominantly in the olfactory epithelium, play crucial roles in the detection of odor molecules. The inhibition of Olr840 involves complex interactions at the molecular level, often mediated by the binding of inhibitor molecules to the active site or allosteric sites of the receptor. This binding can induce conformational changes that either prevent the receptor from interacting with its natural ligands or impede the downstream signaling pathways essential for olfactory perception. Structurally, Olr840 inhibitors are diverse, encompassing small organic molecules, peptides, and even larger biomolecular entities, each designed to achieve high specificity and affinity for the receptor.
The chemical diversity of Olr840 inhibitors allows for extensive exploration in understanding receptor-ligand interactions, receptor activation mechanisms, and the broader implications for olfactory signal transduction. By studying these inhibitors, researchers can elucidate the structural features of Olr840, such as the arrangement of transmembrane domains, ligand-binding pockets, and key amino acid residues critical for receptor function. Additionally, these inhibitors serve as valuable tools in dissecting the functional role of Olr840 within the olfactory system and beyond, providing insights into the molecular basis of odor recognition and signal propagation. Advanced techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and molecular docking simulations are often employed to study the binding interactions and structural dynamics of Olr840 inhibitors, contributing to a comprehensive understanding of their inhibitory mechanisms and potential applications in scientific research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Beta-adrenergic antagonist, might modulate GPCR activity potentially affecting Olr840. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $124.00 $240.00 $530.00 $999.00 $1530.00 | 2 | |
Beta-adrenergic antagonist with alpha-1 blocking activity, could influence Olr840 signaling. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Alpha-2 adrenergic receptor antagonist, may affect GPCR signaling pathways related to Olr840. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $180.00 | ||
Combined alpha and beta blocker, could indirectly affect GPCR pathways including Olr840. | ||||||
Pindolol | 13523-86-9 | sc-204847 sc-204847A | 100 mg 1 g | $194.00 $760.00 | ||
Beta-adrenergic antagonist, may influence GPCR-mediated signaling pathways related to Olr840. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist, could indirectly affect Olr840 through GPCR modulation. | ||||||
Atropine | 51-55-8 | sc-252392 | 5 g | $204.00 | 2 | |
Muscarinic acetylcholine receptor antagonist, may influence GPCR signaling pathways including Olr840. | ||||||
Salmeterol | 89365-50-4 | sc-224277 sc-224277A | 10 mg 50 mg | $186.00 $562.00 | 1 | |
Beta-2 adrenergic agonist, potentially affecting GPCR pathways related to Olr840. | ||||||
Alprenolol | 13655-52-2 | sc-507469 | 50 mg | $130.00 | ||
Beta blocker, could indirectly influence GPCR signaling pathways including Olr840. | ||||||